Skip to main content
. 2020 Jul 8;47(10):1713–1722. doi: 10.1111/1440-1681.13309

Figure 1.

Figure 1

Diosmetin enhances the proliferation marker proteins of Ki67 and expression of the ratio of Bcl‐2/Bax in MI model rats. A, Comparison of Ki67 expression proteins in myocardial cells detected by immunohistochemical staining from Sham group, MI model group, low‐dose group (50 mg/kg diosmetin), medium‐dose group (100 mg/kg diosmetin) and high‐dose group (200 mg/kg diosmetin). Magnification 200×. B, Semi‐quantitative analysis of the relative amounts of Ki67 in each group of neonatal rats. C, Relative mRNA level ratio of Bcl‐2/Bax detected by RT‐qPCR in each group of neonatal rats. D, A representative result for western blot analysis Bcl‐2 and Bax. E, Semi‐quantitative analysis of the relative amounts’ ratio of Bcl‐2/Bax in each group of neonatal rats. The results were presented as mean ± SD and represent three individual experiments. (*P < .05 vs sham group, #P < .05 vs MI model group, ##P < .01 vs MI model group) Inline graphic, Control; Inline graphic, MI model; Inline graphic, Diosmetin 50; Inline graphic, Diosmetin 100; Inline graphic, Diosmetin 200; Inline graphic, Control; Inline graphic, MI model; Inline graphic, Diosmetin 50; Inline graphic, Diosmetin 100; Inline graphic, Diosmetin 200; Inline graphic, Control; Inline graphic, MI model; Inline graphic, Diosmetin 50; Inline graphic, Diosmetin 100; Inline graphic, Diosmetin 200